We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

82 hedge funds and large institutions have $272M invested in Albireo Pharma Inc in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

295% more call options, than puts

Call options by funds: $4.75M | Put options by funds: $1.2M

79% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 19

57% more capital invested

Capital invested by funds: $173M → $272M (+$98.7M)

19% more funds holding

Funds holding: 69 → 82 (+13)

Holders
82
Holders Change
+13
Holders Change %
+18.84%
% of All Funds
1.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
34
Reduced
19
Closed
4
Calls
$4.75M
Puts
$1.2M
Net Calls
+$3.54M
Net Calls Change
+$930K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.32M
2
Marshall Wace
Marshall Wace
United Kingdom
+$2M
3
Deutsche Bank
Deutsche Bank
Germany
+$1.4M
4
SCM
Suvretta Capital Management
New York
+$752K
5
DCM
Driehaus Capital Management
Illinois
+$708K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.02M
2
Victory Capital Management
Victory Capital Management
Texas
-$5.9M
3
PM
Prosight Management
Texas
-$3.1M
4
AG
Artal Group
Luxembourg
-$2.07M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$949K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$51.9M – – –
Federated Hermes
2
Federated Hermes
Pennsylvania
$50.7M – – –
ACH
3
ArrowMark Colorado Holdings
Colorado
$25.4M -$363K -15,382 -2%
BlackRock
4
BlackRock
New York
$24.1M +$3.32M +140,806 +18%
CC
5
Chicago Capital
Illinois
$13.3M +$220K +9,334 +2%
AG
6
Artal Group
Luxembourg
$13.3M -$2.07M -87,765 -15%
BBA
7
Baker Bros. Advisors
New York
$9.78M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$6.62M +$356K +15,107 +6%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$6.47M +$215K +9,096 +4%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$6.24M -$949K -40,250 -15%
State Street
11
State Street
Massachusetts
$6M +$158K +6,709 +3%
PM
12
Prosight Management
Texas
$5.27M -$3.1M -131,607 -40%
Northern Trust
13
Northern Trust
Illinois
$5.25M +$531K +22,501 +13%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$5.03M +$183K +7,745 +4%
Point72 Asset Management
15
Point72 Asset Management
Connecticut
$4.64M -$8.02M -340,000 -66%
HA
16
Heartland Advisors
Wisconsin
$3.97M – – –
Deutsche Bank
17
Deutsche Bank
Germany
$3.1M +$1.4M +59,334 +102%
Marshall Wace
18
Marshall Wace
United Kingdom
$2.25M +$2M +84,826 New
SCM
19
Suvretta Capital Management
New York
$2.14M +$752K +31,900 +65%
EP
20
Eversept Partners
New York
$2.07M – – –
N
21
Nuveen
North Carolina
$1.68M +$284K +12,030 +23%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.44M +$222K +9,426 +21%
BC
23
Birchview Capital
Vermont
$1.27M – – –
Victory Capital Management
24
Victory Capital Management
Texas
$1.23M -$5.9M -250,106 -84%
WMSA
25
Weiss Multi-Strategy Advisers
New York
$1.06M -$78.7K -3,337 -8%
1
2 3 4

ALBO Hedge Fund Activity: Q2 2020 in Review

82 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2020, worth a combined $272M — up 57% from $173M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ALBO positions and 4 closed out — a net gain of 13 holders — while 34 added to existing stakes and 19 trimmed.

The largest buyer was BlackRock, adding an estimated $3.32M. The largest seller was Point72 Asset Management, cutting an estimated $8.02M.

  • 82 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2020, up from 69 in Q1 2020.
  • Funds reported $272M of Albireo Pharma Inc stock for Q2 2020, up 57% quarter-over-quarter.
  • 17 funds opened new Albireo Pharma Inc positions in Q2 2020 and 4 closed out, a net change of +13 holders.
  • The largest Albireo Pharma Inc buyer in Q2 2020 was BlackRock, an estimated $3.32M added.
  • The largest Albireo Pharma Inc seller in Q2 2020 was Point72 Asset Management, an estimated $8.02M sold.

Based on aggregated 13F filings for Q2 2020.